MediCeption Science Pvt Ltd
Dr. Punit Srivastava serves as the Director and Chief Scientific Officer at MediCeption Science Pvt Ltd since January 2016, overseeing clinical trial support services, regulatory studies, medico-marketing, and market research activities, managing over 50 projects for leading pharmaceutical companies. Prior to this role, Dr. Srivastava worked at Daiichi Sankyo, Inc. from July 2010 to December 2016 as Assistant Director, leading projects in respiratory inflammation, autoimmune disorders, and infectious diseases. Additionally, Dr. Srivastava held the position of Group Leader at Ranbaxy Research Laboratories from October 2004 to June 2010, where significant contributions were made in similar therapeutic areas, including the identification of a molecule currently being evaluated in Phase II clinical trials for COPD. Early career experience includes serving as a Senior Research Fellow at the University of Connecticut and a post-doctoral fellowship in pharmacology and toxicology at the Medical College of Wisconsin. Academic credentials include a Doctorate in Pharmacology from Banaras Hindu University.
This person is not in any teams
MediCeption Science Pvt Ltd
MEDICEPTION is working towards excellence in the Medical & Clinical Research space and believes in pursuing business through innovation and technology. We have expertise in Clinical trial support services, Regulatory documentation and filings, Medico-Marketing and Medical Writing services. Our team comes with several years of industry experience, and comprise of a highly motivated set of specialists & pharma industry experts. We grow through creativity and innovation. We integrate honesty, integrity and business ethics into all aspects of our business functioning. MEDICEPTION offers: - End to End clinical trial support services - Regulatory documentations & Regulatory filing consultations - Medico-marketing collateral - Assistance with high standard Medical writing services